Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bornholdt

Showing results (261-270 of 289) with videos related to

Pageof 29
Sort By:
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Cell Systems|November 17, 2022
Morphology and gene expression profiling provide complementary information for mapping cell stateGregory P Way, Ted Natoli, Adeniyi Adeboye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccineAnna Z Wec, Denise Haslwanter, Yasmina N Abdiche, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Human Molecular Genetics|August 11, 1999
Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndromeM Kalff-Suske, A Wild, J Topp, et al.
Cell Host & Microbe|January 9, 2022
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodiesDenise Haslwanter, Gorka Lasso, Anna Z Wec, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 29

Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Pathogens (Basel, Switzerland)|June 24, 2022
Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a Pan-Ebolavirus ImmunotherapeuticErin Kuang, Robert W Cross, Maria McCavitt-Malvido, et al.
Cell Reports|September 1, 2021
Cooperativity mediated by rationally selected combinations of human monoclonal antibodies targeting the henipavirus receptor binding proteinMichael P Doyle, Nurgun Kose, Viktoriya Borisevich, et al.
Cell Systems|November 17, 2022
Morphology and gene expression profiling provide complementary information for mapping cell stateGregory P Way, Ted Natoli, Adeniyi Adeboye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2020
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccineAnna Z Wec, Denise Haslwanter, Yasmina N Abdiche, et al.
Mbio|April 16, 2025
Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virusAlbert Wang, Stephanie R Monticelli, Ariel S Wirchnianski, et al.
JCI Insight|April 12, 2022
Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus diseaseRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2021
Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibodyLarry Zeitlin, Robert W Cross, Joan B Geisbert, et al.
Human Molecular Genetics|August 11, 1999
Point mutations throughout the GLI3 gene cause Greig cephalopolysyndactyly syndromeM Kalff-Suske, A Wild, J Topp, et al.
Cell Host & Microbe|January 9, 2022
Genotype-specific features reduce the susceptibility of South American yellow fever virus strains to vaccine-induced antibodiesDenise Haslwanter, Gorka Lasso, Anna Z Wec, et al.
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Pageof 29